Danaher Corp logo

Danaher Corp (DHR)

Market Closed
24 Jan, 20:00
NYSE NYSE
$
245. 82
+0.16
+0.07%
After Hours
$
245. 82
0 0%
176.57B Market Cap
28.65 P/E Ratio
1.08% Div Yield
3,044,238 Volume
7.58 Eps
$ 245.66
Previous Close
Day Range
245.02 247.53
Year Range
225.42 281.7
Earnings results expected in 4 days

Summary

DHR closed today higher at $245.82, an increase of 0.07% from yesterday's close, completing a monthly increase of 6.48% or $14.97. Over the past 12 months, DHR stock gained 6.48%.
DHR pays dividends to its shareholders, with the most recent payment made on Oct 25, 2024. The next announced payment will be in In 1 week on Jan 31, 2025 for a total of $0.27.
The last earnings report, released on Oct 22, 2024, exceeded the consensus estimates by 0.14%. On average, the company has surpassed earnings expectations by 0.17%, based on the last three reports. The next scheduled earnings report is due on Jan 28, 2025.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track DHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

DHR Chart

FAQ

What Is the Danaher Corp(DHR) Stock Price Today?

The DHR stock price today is $245.82.

What Stock Exchange Does Danaher Corp Trade On?

Danaher Corp is listed and trades on the NYSE.

What Is the Stock Symbol for Danaher Corp?

The stock symbol for Danaher Corp is "DHR".

Does Danaher Corp Pay Dividends? What's The Current Dividend Yield?

DHR is not paying dividends to its shareholders.

What Is the Danaher Corp Market Cap?

As of today, Danaher Corp market cap is 176.57B.

What is Danaher Corp Earnings Per Share?

The Danaher Corp EPS is 2.14.

What Is the Next Danaher Corp Earnings Date?

Danaher Corp will release its next earnings report on Jan 28, 2025.

Did Danaher Corp had any splits?

No, Danaher Corp has never had a stock split.

Danaher Corp Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Steven M. Rales CEO
NYSE Exchange
US2358511028 ISIN
US Country
61,000 Employees
27 Dec 2024 Last Dividend
2 Oct 2023 Last Split
5 Jan 1979 IPO Date

Overview

Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.

Products and Services

  • Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
  • Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
  • Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.

Contact Information

Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone: 202 828 0850